Upload
shirakawa-almira
View
228
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Cardiology
Citation preview
Treating Atrial Fibrillation
Richard SchillingSt Bartholomew's Hospital, Queen Marys University of London
AF burdenFraminghamLifetime risk of developing AF = 25%Mortality: SMR =1.9 1.5 NHS audit1% of budget spent on AF - 688, 000, 000 in 2000Quality of life Symptoms of AFSide effects of medication
Benjamin, E. J. et al. "Impact of atrial fibrillation on the risk of death: the Framingham Heart Study." Circulation 98.10 (1998): 946-52.Stewart, S. et al. "Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK." Heart 90.3 (2004): 286-92
ATRIAL FIBRILLATIONIncidenceFraminghamHeart Study
Nice guidance for management of AFIssued on June 2006Aimed to give a UK based simple guidance on management of AFAttempts to be evidence basedAnd applicable to the majority of patients
Key aims of managementDiagnosis - everyone with irregular pulse gets ECGIdentify secondary causes (thyroid, hypertension, valve disease)Treatment Stroke preventionRate controlRhythm control where appropriate
DiagnosisAF can only be diagnosed on an ECG recorded during symptoms/signsEven asymptomatic patients should have an ECGConsider 24 hour to 7 day Holter if intermittent (depending on frequency)Or ask patient to attend A+E during symptoms and get a copy of ECG
InvestigationTFTEchoIf youngIf rhythm control strategyIf unsure of stroke riskIf structural heart disease suspected
Stroke preventionWarfarin (INR 2-3)Aspirin
Rate control vs rhythm controlRACEMortality 22.6% vs 17.2%39% vs 10% in SR AFFIRMMortality 23.8% vs 21.3 % hospitalisation Side effectsSR has a prognostic benefit
Rhythm control - problemCardioversion and drugs maintains SR in 42% at one year (amiodarone)Side effects require stopping amiodarone in 25%Anticoagulation stopped too early
Treatment decision tree
Advantages of Warfarin over Aspirin
Advantages of Warfarin over Aspirin
rhythm vs rate control
Persistent AF rate controlSpecialist referral
Rhythm control
Rate control vs Rhythm controlAF is dangerousSR is better and confers mortality benefit Conventional therapies are poor at maintaining SR The population is aging
What specialist treatments are available?Antiarrhythmic drugsPacemakerCatheter ablationSurgical ablation
AV node ablation and pacing
AV node ablation and pacinghides the AFEasy to perform (99%) successNo atrial transport (turbo)Pacing dependent (LBBB)No going backRefuge of the elderly and desperate
The first curative procedure MazeJL Cox et al 1991
Why does the maze work?
Radiofrequency Ablation CatheterLesion cross-section
How is RF energy applied
RFA Lesion - Macroscopic
Atrial fibrillation originates in the left atrium
Mechanisms for AF
Target PV triggerLIMITED BY:Absence of spontaneous ectopyMultiple triggers
Focal AF: RFA to disconnect PV potential
Continuous circular lesions
Catheter ablation in permanent AFEarley et al. Heart 2005MV31/41(76%) in SR at 8.4 mths
The electroanatomical approachThe anatomy is very stylisedAccurate lesion location is very dependent on experience
CT integrationTrue 3-dimensional anatomy with catheter localisation
Creating 3 landmark pairs
LPV locations of interest
LPV internal view
Does this have a clinical effect?LUPVLAALLPVAblation lines
Isolation of LPVs during AF
Practicalities of curative AF ablationPre op - CT few weeks pre-opTOE on dayACT >300 during procedureProcedure time 2-3 hours PAF/ 3-4 hours PersistentPost-op echoWarfarin loading on night of procedureContinues for 3 months if low riskEnoxaparin day after until INR>2
Case Control Study of 3-D mapping vs CT integration105 patients6 month follow up7 day holter at 3 monthsSimilar operator profile and experience
AF ablation results
Freedom from AT/AFoff medication at 6 month follow upCT integration(n = 53)3D mapping(n = 52)P value
How does ablation compare to drugs?
Ablation vs drugs
Does ablation improve prognosis?Pappone et al circulation 2001
AblationN=589MedicalN=582Death3883Adverse events54117
Complications of AF ablation
AF ablation is good for your garden
Preliminary results2 pts recurrence after ablation awaiting redo6pts improved >1 NYHA5% EF after 1 month
Limitations of AF ablationHigh volume does make a differenceRedos are commonTarrif does not reflect costSerious complications are increasingly rare but do occurTeam work is critical
ConclusionAF is commonPriorities for treatment now clearly definedCure is now possible but at a costThe lost tribe of AF sufferers now have hopeThe epidemic may have a solutionwww.londonafcentre.com
One can never overstate the enormity of the problem that AF pesents to cliniciansData from Frammingham has shown us that 1in 4 people over the age of 40 will develop AF. And once standardising for all other factors it is ass with an increased mortalityA recent economic analysis published in heart this year estimatedbased on 1995 figuresQuality of life .
First descrip by JL Cox et al from the united state in 1991 as surgical treatment of AF
It involed multiple sugical incisions in both atria to produre electrical barrier prevent re-entry circuit.
Howevere the procedure is performed on bypass and
The procedure has been fine-tuned in subsequent years.The success rate is operator dependent.
From Dr. Cox seriers on 164 patients the reported 100% in restoring sinus rhytm and 7% of those patient require anti-arrhytmic therapy afterward
Having said that because this procedure required mutiple atriotomy, it increases the cardiopulmonary bypass time.
The epicardial Maze one the otherhand is done off bypass. And perhaps this is an alternative technique which need to be investigated.